This MedLibrary.org supplementary page on Emil Adolf von Behring is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Emil Adolf von Behring | |
 Emil Adolf von Behring
|
|
| Born | March 15, 1854 Hansdorf |
|---|---|
| Died | March 31, 1917 Marburg, Hesse-Nassau |
| Nationality | Germany |
| Fields | Physiology, immunology |
| Known for | Diphtheria vaccine |
| Notable awards | Nobel Prize in Physiology or Medicine (1901) |
Emil Adolf von Behring (March 15, 1854 – March 31, 1917) was a German physiologist who received the 1901 Nobel Prize in Physiology or Medicine.
Contents |
Biography
Behring was born Adolf Emil Behring in Hansdorf, Kreis Rosenberg, Province of Prussia.
Between 1874 and 1878 he studied medicine at the Akademie für das militärärztliche Bildungswesen, Berlin. He was mainly a military doctor and then became Professor of Hygienics within the Faculty of Medicine at the University of Marburg (against the initial strenuous opposition of the faculty council), a position he would hold for the rest of his life.
Behring was the discoverer of diphtheria antitoxin and attained a great reputation by that means and by his contributions to the study of immunity. He won the first Nobel Prize in Physiology or Medicine in 1901 for developing a serum therapy against diphtheria (this was worked on with Emile Roux) and tetanus. The former had been a scourge of the population, especially children, whereas the other was a leading cause of death in wars, killing the wounded. At the International Tuberculosis Congress in 1905 he announced that he had discovered "a substance proceeding from the virus of tuberculosis." This substance, which he designated "T C", plays the important part in the immunizing action of Professor Behring's "bovivaccine", which prevents bovine tuberculosis.
Behring died at Marburg, Hessen-Nassau, on March 31, 1917. His name survives in Dade Behring, the world's largest company dedicated solely to clinical diagnostics, in CSL Behring a manufacturer of plasma-derived biotherapies, in Behringwerke AG in Marburg, in Novartis Behring and in the Emil von Behring Prize of the University of Marburg, the highest endowed medicine award in Germany.
His Nobel Prize medal, is now kept on display at the International Red Cross and Red Crescent Museum in Geneva.
Publications
- Die Blutserumtherapie (1892)
- Bekämpfung der Infektionskrankheiten (1894)
- Beiträge zur experimentellen Therapie (1906)
References
- Karoline Grundmann (3 December 2001). "Emil von Behring: The founder of serum therapy". The Nobel Foundation. Retrieved on 2008-07-21.
- This article incorporates text from an edition of the New International Encyclopedia that is in the public domain.
External links
|
||||||||
Wikipedia content modification information:
- This page was last modified on 26 September 2008, at 22:35.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Emil Adolf von Behring".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.